AEGERION PHARMACEUTICALS INC - NOTE 2.000% 8/1

Historical Holders from Q3 2015 to Q3 2019

Type / Class
Debt / NOTE 2.000% 8/1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of AEGERION PHARMACEUTICALS INC - NOTE 2.000% 8/1 across Reporting Periods

Period Principal Value Change Price (% of par) Investors
2019 Q3 $0 $0 -$36,674,000 0
2019 Q2 $52,392,000 $36,674,000 -$158,977,000 70.0% 1
2019 Q1 $275,922,000 $195,651,000 -$21,007,000 68.25% 11
2018 Q4 $301,922,000 $235,262,000 -$17,055,998 75.82% 12
2018 Q3 $325,922,000 $242,637,000 +$3,107,009 74.99% 13
2018 Q2 $322,922,000 $215,930,000 -$861,107 64.89% 15
2018 Q1 $323,422,000 $252,271,000 -$1,339,655 77.34% 14
2017 Q4 $324,980,000 $261,810,000 +$1,199,224 79.57% 16
2017 Q3 $228,435,000 $183,797,000 +$1,680,496 79.72% 16
2017 Q2 $226,483,400 $183,384,428 +$3,384,778 80.82% 20
2017 Q1 $222,654,000 $185,699,000 -$5,693,713 80.86% 19
2016 Q4 $231,931,000 $166,359,350 +$956,365 71.43% 18
2016 Q3 $231,147,000 $153,251,085 -$12,197,203 66.0% 19
2016 Q2 $253,996,000 $144,127,000 +$2,153,827 57.0% 24
2016 Q1 $251,498,500 $130,172,034 -$15,804,882 50.82% 24
2015 Q4 $344,442,500 $228,110,379 +$1,251,721 66.4% 30
2015 Q3 $291,967,500 $220,710,621 +$196,009,621 75.3% 29